Patents by Inventor Paul Meng

Paul Meng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl Compounds as Ligand Directed Degraders of IRAK4
    Publication number: 20240109881
    Abstract: Provided herein are compounds and compositions thereof for modulating IRAK4. In some embodiments, the compounds and compositions are provided for treatment of inflammatory or autoimmune diseases.
    Type: Application
    Filed: July 19, 2023
    Publication date: April 4, 2024
    Applicants: Bristol-Myers Squibb Company, Celgene Corporation
    Inventors: Timothy Rasmusson, Geraint Davies, Paul Gormisky, Rulin Ma, Michael Ellis, Lingbowei Hu, Tony Siu, Farid van der Mei, Harry Hager, Yilin Meng
  • Pitch reduction technology using alternating spacer depositions during the formation of a semiconductor device and systems including same
    Patent number: 11935756
    Abstract: A method for patterning a layer increases the density of features formed over an initial patterning layer using a series of self-aligned spacers. A layer to be etched is provided, then an initial sacrificial patterning layer, for example formed using optical lithography, is formed over the layer to be etched. Depending on the embodiment, the patterning layer may be trimmed, then a series of spacer layers formed and etched. The number of spacer layers and their target dimensions depends on the desired increase in feature density. An in-process semiconductor device and electronic system is also described.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: March 19, 2024
    Inventors: Baosuo Zhou, Mirzafer K. Abatchev, Ardavan Niroomand, Paul A. Morgan, Shuang Meng, Joseph Neil Greeley, Brian J. Coppa
  • Formulated polyol compositions
    Patent number: 11932722
    Abstract: Embodiments of the present disclosure are directed towards formulated polyol compositions that include a first polyether polyol having an average hydroxyl number from 112 to 280 mg KOH/g, a second polyether polyol having an average hydroxyl number from 18.5 to 51 mg KOH/g, a third polyether polyol having an average hydroxyl number from 20 to 70 mg KOH/g, and at least one of: fourth polyether polyol having an average hydroxyl number from 112 to 280 mg KOH/g; and a methoxypolyethylene glycol having an average hydroxyl number from 56 to 190 mg KOH/g.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: March 19, 2024
    Assignee: Dow Global Technologies LLC
    Inventors: Qinghao Meng, Lucie Porcelli, David J. Honkomp, Meagan Broadway, Morgan A. Springs, Paul Cookson, William L. Ritter, Anja Arlt
  • Liquid pharmaceutical form of alkylphosphocholine and method for preparing same
    Patent number: 8722648
    Abstract: The inventions relates to a liquid pharmaceutical form containing an active ingredient alkylphosphocholines and a co-solvent system. The co-solvent system is mixture from hexylene glycol, propylene glycol, diethylene glycol monoethyl ether and water. The pharmaceutical form having a pH value in the range of 4 to 6, which if it is necessary can be achieved by adding a pH adjuster. The composition has a good storage stability and it is suitable for local application on the different organs of the body. The inventions relates also to a method for producing the same pharmaceutical form.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: May 13, 2014
    Inventor: Paul Meng
  • Liquid Pharmaceutical Form Of Alkylphosphocholine And Method For Preparing Same
    Publication number: 20120115814
    Abstract: The inventions relates to a liquid pharmaceutical form containing an active ingredient alkylphosphocholines and a co-solvent system. The co-solvent system is mixture from hexylene glycol, propylene glycol, diethylene glycol monoethyl ether and water. The pharmaceutical form having a pH value in the range of 4 to 6, which if it is necessary can be achieved by adding a pH adjuster. The composition has a good storage stability and it is suitable for local application on the different organs of the body. The inventions relates also to a method for producing the same pharmaceutical form.
    Type: Application
    Filed: July 9, 2009
    Publication date: May 10, 2012
    Applicant: EXPERGEN DRUG DEVELOPMENT GMBH
    Inventor: Paul Meng